Diferencia entre revisiones de «Template:Bell's palsy Treatment»
(Fix cite errors: add content to empty bells guidelines ref, fix Gronseth ref reuse to self-closing tag) |
(Fix cite error: convert bells guidelines named ref to unnamed to prevent conflict with main page definition) |
||
| Línea 1: | Línea 1: | ||
===Eye Protection=== | ===Eye Protection=== | ||
*Cornea eye protection ([[EBQ:Evidence Levels|Level X]])<ref | *Cornea eye protection ([[EBQ:Evidence Levels|Level X]])<ref>Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-S27.</ref> | ||
**Artificial tears qhr while patient is awake | **Artificial tears qhr while patient is awake | ||
**Ophthalmic ointment at night | **Ophthalmic ointment at night | ||
Revisión actual - 01:10 21 mar 2026
Eye Protection
- Cornea eye protection (Level X)[1]
- Artificial tears qhr while patient is awake
- Ophthalmic ointment at night
- Eye should be taped shut at night
- Protective glasses or goggles
Steroids
Should be started within 72hrs of symptom onset[2]
- Prednisone 60-80mg qday x1wk[3] (Level B Evidence)[4]
Antivirals
Most likely no added benefit when combined with steroids.[5] However also little harm associated with antivirals especially in patients with normal renal function[4]
- Valacyclovir 1000mg TID x1 week OR
- Acyclovir 400mg 5x per day x1 week
Antibiotics
- Consider empiric empiric dosing if high index of suspicion for Lyme based on clinical presentation or lab data
- ↑ Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg. 2013;149(3 Suppl):S1-S27.
- ↑ Vargish L. For Bell's palsy, start steroids early; no need for an antiviral. J Fam Pract. Jan 2008; 57(1): 22–25http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3183838/pdf/JFP-57-22.pdf
- ↑ UpToDate. Bell's Palsy Prognosis and Treatment. March, 2014
- ↑ 4.0 4.1 Gronseth GS, Paduga R. Evidence-based guideline update: Steroids and antivirals for Bell palsy: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012Full Text
- ↑ Lockhart et al. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD001869.